Fundraising Fox

Antheia, Inc.

Menlo Park, US · Founded 2013 · Delaware corporation · 67 employees on LinkedIn · 7 known investors

Find your way into Antheia, Inc.

113 people in our graph share verified history with the Antheia, Inc. team — schools, employers, funds. One of them is your warm intro.

Susannah Barbeeunlockedknows Kristy Hawkins · together at Caltech (overlapped)
knows the team · via Texas A&M University
×4knows the team · via Caltech
×3knows the team · via Amyris
×2knows the team · via Eastman Chemical Company
knows the team · via Antheia, Inc.

Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.

Advanced ManufacturingBiotechHealthtech

Founders & leadership

Antheia, Inc. was founded in 2013 by Christina D. Smolke, Christina Smolke, and Kristy Hawkins.

CDChristina D. Smolke
Christina D. SmolkeinCEO & Co-Founder
CSChristina Smolke
Christina SmolkeinCo-Founder & CEO
KHKristy Hawkins
Kristy HawkinsinCo-Founder & CSOKristy Hawkins is a co-founder and Chief Science Officer of Antheia, bringing over 15 years of experience in synthetic biology and yeast metabolic engineering for small molecule production. Her expertise spans tool development, high-throughput screening, and pathway engineering applied to fermentation-based pharmaceutical manufacturing.
EDEric d'Esparbes
Eric d'EsparbesinChief Financial Officer
ZMZack McGahey
Zack McGaheyinChief Operating Officer
HPHeidi Pucel
Heidi PucelinChief People Officer

Board

RS
Ram ShriramBoard director
CT
Catherine ThodeyBoard director

Investors · 7

America's Frontier FundArlington · $500K – $10M
Civilization Ventures Management, LlcTiburon · $1M – $10M
Lam Capital
Sherpalo VenturesMenlo Park
Global Health Investment CorporationreportedNew York

Also in the syndicate · 2

ATHOS KGleadEDBI

Funding

SEC filings, press & company announcements

$97.4M disclosed across 5 rounds · 2015–2026

▶$9.2MraisedSep 2018 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ram ShriramDirector
  • Valerie MinassianExecutive Officer
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
Offering amount
$15.5M
Amount sold
$9.2M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedMay 2017 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
  • Ram ShriramDirector
Offering amount
$25M
Amount sold
$6.2M
First sale
May 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2015 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ram ShriramDirector
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2M
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Antheia, Inc. went on to found or lead other companies.

Jean SiniInvestorFounded Irregular ExpressionsAaron CravensConsultantFounded Revel PharmaceuticalsPatrick Y. YangBoard DirectorFounded Acepodia

In the news

Antheia seals 2nd series C funding close, hitting more than $175M in a yearfiercepharma.com · Jan 2026Antheia Raises $24M in Second Close of Series C Financingfinsmes.com · Jan 2026Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Yearprnewswire.com · Jan 2026Antheia Raises $56M in Series C Fundingfinsmes.com · Jun 2025Medpathtrial.medpath.com · Jun 2025Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy - Antheiaantheia.bio · Jun 2025

Frequently asked questions

What does Antheia, Inc. do?
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.
Who founded Antheia, Inc.?
Antheia, Inc. was founded by Christina D. Smolke, Christina Smolke, Kristy Hawkins in 2013.
Who are Antheia, Inc.'s investors?
Antheia, Inc.'s investors include America's Frontier Fund, Civilization Ventures Management, Llc, Lam Capital, Sherpalo Ventures, Global Health Investment Corporation.
How much funding has Antheia, Inc. raised?
Antheia, Inc. has disclosed $97.4M raised across 5 rounds.
Where is Antheia, Inc. headquartered?
Antheia, Inc. is headquartered in Menlo Park, US.